Patents by Inventor Michel Guerineau

Michel Guerineau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7255989
    Abstract: The invention concerns a method for preparing nucleic acids from an environment sample, more particularly a method for obtaining a library of nucleic acids from a sample. The invention also concerns nucleic acids of nucleic acid libraries obtained by said method their use in the synthesis of novel compounds, in particular novel compounds of therapeutic interest. The invent further concerns novel means used in the method for obtaining said nucleic acids, such as novel vectors and novel processes for preparing such vectors or recombinant host cells containing said nucleic acid. Finally, the invention concerns methods for detecting a nucleic acid of interest within a library of nucleic acids resulting from said method, and nucleic acids detected by said method and polypeptides encoded by said nucleic acids.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: August 14, 2007
    Assignee: Aventis Pharma S.A.
    Inventors: Pascale Jeannin, Jean-Luc Pernodet, Michel Guerineau, Pascal Simonet, Sophie Courtois, Camela Cappellano, François Francou, Alain Raynal, Maria Ball, Guennadi Sezonov, Karine Tuphile, Asa Frostegard
  • Patent number: 5741675
    Abstract: Novel nucleic acid sequences, vectors for expressing same, and uses of said sequences, in particular in actinomycetes fermentation methods.
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: April 21, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Annick Friedmann, Michel Guerineau, Juliette Hagege, Jean-Luc Pernodet, Guennady Sezonov
  • Patent number: 5688689
    Abstract: The present invention relates to a vector for cloning and expression of a DNA sequence coding for a particular protein in an Actynomycetes strain. The process comprises:an attachment sequence att,a DNA sequence coding for an int sequnce functional in said strain, anda DNA sequence coding for said specific protein and for the elements ensuring the expression of said sequence in said strain.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 18, 1997
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Tamara Smokvina, Frederic Boccard, Michel Guerineau
  • Patent number: 4387162
    Abstract: A hybrid plasmid comprising at least the DNA of a bacterial plasmid, all or part of the DNA of the 2.mu. plasmid of yeast and a segment of DNA including the gene URA.sub.3.sup.+ of yeast. These plasmids are useful as vectors of exogenous DNA in yeasts.
    Type: Grant
    Filed: November 14, 1979
    Date of Patent: June 7, 1983
    Assignee: Agence Nationale de Valorisation de la Recherche (ANVAR)
    Inventors: Michel Aigle, Hughes Blanc, Philippe Fournier, Claude Gerbaud, Michel Guerineau, Henri Heslot, Francois Lacroute
  • Patent number: 4264732
    Abstract: The invention relates to enzymatic compositions containing intra-cellular glucose-isomerase which is enclosed in structures based on cellulose ester, their preparation and their use for isomerizing glucose into levulose.In addition to the cellulose ester and micro-organism cells, e.g. Streptomyces phaeochromogenes, these compositions contain a sparingly water-soluble magnesium compound and optionally a sparingly water-soluble cobalt compound.These compositions make it possible to isomerize glucose into levulose in a continuous process, with the addition of either no, or a small amount of magnesium ions to the glucose syrup to be isomerized and without the addition of cobalt ions.
    Type: Grant
    Filed: July 21, 1978
    Date of Patent: April 28, 1981
    Assignee: Rhone-Poulenc Industries
    Inventors: Guy Lartigau, Albert Bouniot, Michel Guerineau
  • Patent number: 3990943
    Abstract: A process for the enzymatic isomerization of glucose to fructose where the glucose isomerase is combined with magnesium or magnesium and cobalt ions which have been fixed to a cation exchange resin. The glucose isomerase remains combined with the metal ions during the isomerization. The use of the instant complex prolongs the working life of the enzyme and minimizes the need for conventional pH control.
    Type: Grant
    Filed: September 25, 1974
    Date of Patent: November 9, 1976
    Assignee: Rhone-Poulenc S.A.
    Inventors: Albert Bouniot, Michel Guerineau